528 related articles for article (PubMed ID: 38188647)
21. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments.
Castro F; Martins C; Silveira MJ; Moura RP; Pereira CL; Sarmento B
Adv Drug Deliv Rev; 2021 Mar; 170():312-339. PubMed ID: 32946921
[TBL] [Abstract][Full Text] [Related]
22. Cell membrane-based biomimetic nanosystems for advanced drug delivery in cancer therapy: A comprehensive review.
Zhao J; Ruan J; Lv G; Shan Q; Fan Z; Wang H; Du Y; Ling L
Colloids Surf B Biointerfaces; 2022 Jul; 215():112503. PubMed ID: 35429736
[TBL] [Abstract][Full Text] [Related]
23. Cell primitive-based biomimetic functional materials for enhanced cancer therapy.
Luo GF; Chen WH; Zeng X; Zhang XZ
Chem Soc Rev; 2021 Jan; 50(2):945-985. PubMed ID: 33226037
[TBL] [Abstract][Full Text] [Related]
24. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
25. Research Progress in Bioinspired Drug Delivery Systems.
Tong Q; Qiu N; Ji J; Ye L; Zhai G
Expert Opin Drug Deliv; 2020 Sep; 17(9):1269-1288. PubMed ID: 32543953
[TBL] [Abstract][Full Text] [Related]
26. Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.
Zhang E; Phan P; Algarni HA; Zhao Z
Pharm Res; 2022 Nov; 39(11):2673-2698. PubMed ID: 35794397
[TBL] [Abstract][Full Text] [Related]
27. Recent progress in targeted delivery vectors based on biomimetic nanoparticles.
Chen L; Hong W; Ren W; Xu T; Qian Z; He Z
Signal Transduct Target Ther; 2021 Jun; 6(1):225. PubMed ID: 34099630
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in cell membrane camouflage-based biosensing application.
Yu X; Sha L; Liu Q; Zhao Y; Fang H; Cao Y; Zhao J
Biosens Bioelectron; 2021 Dec; 194():113623. PubMed ID: 34530371
[TBL] [Abstract][Full Text] [Related]
29. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
[TBL] [Abstract][Full Text] [Related]
30. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery.
Liu JM; Zhang DD; Fang GZ; Wang S
Biomaterials; 2018 May; 165():39-47. PubMed ID: 29501968
[TBL] [Abstract][Full Text] [Related]
31. Red Blood Cell Extracellular Vesicle-Based Drug Delivery: Challenges and Opportunities.
Chiangjong W; Netsirisawan P; Hongeng S; Chutipongtanate S
Front Med (Lausanne); 2021; 8():761362. PubMed ID: 35004730
[TBL] [Abstract][Full Text] [Related]
32. Cell membrane-derived vesicles for delivery of therapeutic agents.
Le QV; Lee J; Lee H; Shim G; Oh YK
Acta Pharm Sin B; 2021 Aug; 11(8):2096-2113. PubMed ID: 34522579
[TBL] [Abstract][Full Text] [Related]
33. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
[TBL] [Abstract][Full Text] [Related]
34. Erythrocyte-inspired delivery systems.
Hu CM; Fang RH; Zhang L
Adv Healthc Mater; 2012 Sep; 1(5):537-47. PubMed ID: 23184788
[TBL] [Abstract][Full Text] [Related]
35. Erythrocyte-based drug delivery in Transfusion Medicine: Wandering questions seeking answers.
Tzounakas VL; Karadimas DG; Papassideri IS; Seghatchian J; Antonelou MH
Transfus Apher Sci; 2017 Aug; 56(4):626-634. PubMed ID: 28774826
[TBL] [Abstract][Full Text] [Related]
36. Biomimetic cell-derived nanocarriers for modulating immune responses.
Qin M; Du G; Sun X
Biomater Sci; 2020 Jan; 8(2):530-543. PubMed ID: 31750453
[TBL] [Abstract][Full Text] [Related]
37. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
38. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
39. Targeting inorganic nanoparticles to tumors using biological membrane-coated technology.
Zhang Y; Chen Q; Zhu Y; Pei M; Wang K; Qu X; Zhang Y; Gao J; Qin H
MedComm (2020); 2022 Dec; 3(4):e192. PubMed ID: 36514780
[TBL] [Abstract][Full Text] [Related]
40. Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K
Wang Y; Zhou C; Ding Y; Liu M; Tai Z; Jin Q; Yang Y; Li Z; Yang M; Gong W; Gao C
Int J Pharm; 2021 Jan; 592():120084. PubMed ID: 33188893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
